. . "In fact, with high-dose lovastatin on board, there was a suggestion that higher BMI actually protected against clinical events (p = 0.06).The results, the researchers conclude, suggest that aggressive treatment with (lovastatin) and potentially with other statins may reverse the adverse effect of obesity on coronary artery disease progression." . .